174 related articles for article (PubMed ID: 23988813)
21. Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
Lee K; Jeong SH; Yoo SH; Ku JH
Investig Clin Urol; 2022 Jan; 63(1):14-20. PubMed ID: 34983118
[TBL] [Abstract][Full Text] [Related]
22. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
Brauers A; Buettner R; Jakse G
J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
24. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.
Hu Z; Mudaliar K; Quek ML; Paner GP; Barkan GA
Ann Diagn Pathol; 2014 Apr; 18(2):49-52. PubMed ID: 24370460
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
26. [INTRAOPERATIVE CONTROL OF THE EFFECTIVENESS OF TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER CANCER].
Zubkov AJ; Sitdykov JN; Nuriev LR; Sitdykova MJ
Urologiia; 2015; (2):65-7. PubMed ID: 26237810
[TBL] [Abstract][Full Text] [Related]
27. Conservative management of low risk superficial bladder tumors.
Pruthi RS; Baldwin N; Bhalani V; Wallen EM
J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
[TBL] [Abstract][Full Text] [Related]
28. Expectant management of small, recurrent, noninvasive papillary bladder tumors.
Soloway MS; Bruck DS; Kim SS
J Urol; 2003 Aug; 170(2 Pt 1):438-41. PubMed ID: 12853794
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre].
Otto W; Fritsche HM; Dirmeyer M; Burger M; Straub M; Rössler W; Wieland WF; Denzinger S
Aktuelle Urol; 2010 Sep; 41(5):316-9. PubMed ID: 20669097
[TBL] [Abstract][Full Text] [Related]
31. Impact of second transurethral resection on recurrence in patients with high-grade Ta bladder cancer.
Taoka R; Matsuoka Y; Kohashiguchi K; Miura T; Tohi Y; Miyauchi Y; Kato T; Tsunemori H; Ueda N; Kakehi Y; Sugimoto M
Int J Urol; 2020 Dec; 27(12):1130-1135. PubMed ID: 32985754
[TBL] [Abstract][Full Text] [Related]
32. Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection.
Deng N; Chen JX; Chen LW; Qiu SP; Li XF; Wang DH
Chin Med J (Engl); 2012 Oct; 125(20):3681-6. PubMed ID: 23075724
[TBL] [Abstract][Full Text] [Related]
33. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
May M; Helke C; Nitzke T; Vogler H; Hoschke B
Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
[TBL] [Abstract][Full Text] [Related]
34. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
Ugurlu O; Gonulalan U; Adsan O; Kosan M; Oztekin V; Cetinkaya M
Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
[TBL] [Abstract][Full Text] [Related]
35. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
37. [Bipolar plasma vaporization--new endoscopic technique in non-invasive bladder cancer].
Geavlete B; Jecu M; Multescu R; Georgescu D; Drăguţescu M; Geavlete P
Chirurgia (Bucur); 2010; 105(2):219-23. PubMed ID: 20540235
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of Horizontal and Vertical Margin of En Bloc Resection for Nonmuscle Invasive Bladder Cancer.
Yanagisawa T; Miki J; Sakanaka K; Fukuokaya W; Iwatani K; Sato S; Obayashi K; Hirooka S; Kimura T; Takahashi H; Egawa S
J Urol; 2021 Aug; 206(2):252-259. PubMed ID: 33780284
[TBL] [Abstract][Full Text] [Related]
39. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
40. Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: the referral cancer center experience and review of the literature.
Han KS; Joung JY; Cho KS; Seo HK; Chung J; Park WS; Lee KH
J Endourol; 2008 Dec; 22(12):2699-704. PubMed ID: 19025393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
